Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ClearPoint Neuro, Inc.MRIC · Entity 2367 | Director | October 04, 2017 | October 05, 2017 |
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Director | October 02, 2020 | October 05, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ClearPoint Neuro, Inc.
Report date October 04, 2017 · Filed October 05, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,902 |
Reported balance
After 2017-10-04 transaction · row 1
1 source rowRow 1 · 2017-10-04 · Grant · Acquired 2,729 · Balance 22,902 F1: These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.47 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 29, 2017. |
| Common StockSEC Table I · non-derivative | IndirectBy Koob Family Trust | 3,850 |
Reported balance
Holding disclosure · report date 2017-10-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,850 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.47 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 29, 2017.
MIMEDX GROUP, INC.
Report date October 02, 2020 · Filed October 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby Family Trust | 1,431,525 |
Reported balance
After 2020-10-02 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-10-02 · Grant · Acquired 26,236 · Balance 1,431,525 F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. Award vests after 12 months. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. Award vests after 12 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2020 Filed Oct 5, 2020 16:13 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 26,236 | $6.67 | $174,994.12 |
DisclosureSEC source: 0001376339-20-000127 · wf-form4_160192879268245.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 1,431,525 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. Award vests after 12 months. Read SEC document |
| September 21, 2020 Filed Sep 24, 2020 16:11 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-20-000107 · wf-form4_160097829975407.xml · nonDerivative · entry 2 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 1,405,289 F1 · shares: This transaction represents a bona fide gift. Read SEC document |
| September 21, 2020 Filed Sep 24, 2020 16:11 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-20-000107 · wf-form4_160097829975407.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 1,455,289 F1 · shares: This transaction represents a bona fide gift. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 16:39 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 29,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-20-000089 · wf-form4_159674632556459.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 1,505,289 F1 · security: On August 5, 2020, based on the closing stock price on that date ($5.90), the Company fixed the number of shares of common stock subject to a previously-granted restricted stock unit award. Award vests upon the earlier of one year or the 2019 annual meeting of shareholders, and will be settled in common stock upon vesting. The grant is exempt under Rule 16b-3. F1 · price: On August 5, 2020, based on the closing stock price on that date ($5.90), the Company fixed the number of shares of common stock subject to a previously-granted restricted stock unit award. Award vests upon the earlier of one year or the 2019 annual meeting of shareholders, and will be settled in common stock upon vesting. The grant is exempt under Rule 16b-3. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 14:46 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Exercise / conversionStock Option · Derivative | 15,000 | $1.20 Strike: $1.20 | $18,000.00 |
DisclosureSEC source: 0001376339-20-000002 · wf-form4_157980879011536.xml · derivative · entry 4 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 14:46 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | OtherCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-20-000002 · wf-form4_157980879011536.xml · nonDerivative · entry 3 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 1,475,628 F2 · kind: This transaction is a mere change in form of beneficial ownership. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 14:46 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | OtherCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-20-000002 · wf-form4_157980879011536.xml · nonDerivative · entry 2 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This transaction is a mere change in form of beneficial ownership. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 14:46 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Exercise / conversionCommon Stock | 15,000 | $1.20 | $18,000.00 |
DisclosureSEC source: 0001376339-20-000002 · wf-form4_157980879011536.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the exercise of a previously-granted stock option. Read SEC document |
| July 09, 2019 Filed Nov 1, 2019 16:53 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | OtherCommon Stock | 723,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-19-000041 · wf-form4_157264161818531.xml · nonDerivative · entry 2 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 1,460,628 F1 · kind: Transaction represents a mere change in form of beneficial ownership - transfer of shares from direct holdings to a family trust. Read SEC document |
| July 09, 2019 Filed Nov 1, 2019 16:53 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | OtherCommon Stock | 723,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-19-000041 · wf-form4_157264161818531.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transaction represents a mere change in form of beneficial ownership - transfer of shares from direct holdings to a family trust. Read SEC document |
| November 22, 2017 Filed Feb 6, 2018 16:08 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-18-000006 · wf-form5_151795126893518.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460,628 F1 · kind: This transaction was a gift. Read SEC document |
| October 04, 2017 Filed Oct 5, 2017 16:18 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantCommon Stock | 2,729 | $2.47 | $6,740.63 |
DisclosureSEC source: 0001534424-17-000419 · koob.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,902 F1 · price: These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.47 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 29, 2017. Read SEC document |
| June 08, 2017 Filed Feb 8, 2019 16:34 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | OtherCommon Stock | 597,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-19-000008 · wf-form5_154966166131747.xml · nonDerivative · entry 4 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 737,474 F1 · kind: Transaction represents a mere change in form of beneficial ownership - transfer of shares from direct holdings to a family trust. Read SEC document |
| June 08, 2017 Filed Feb 8, 2019 16:34 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | OtherCommon Stock | 597,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-19-000008 · wf-form5_154966166131747.xml · nonDerivative · entry 2 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 723,154 F1 · kind: Transaction represents a mere change in form of beneficial ownership - transfer of shares from direct holdings to a family trust. Read SEC document |
| May 17, 2017 Filed May 19, 2017 16:22 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 12,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-17-000100 · wf-form4_149522533413294.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,324,459 F1 · shares: Grant of restricted stock which vests in full on the first anniversary date of the grant. Read SEC document |
| May 01, 2017 Filed May 3, 2017 17:30 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | OtherCommon Stock | 140,168 | $13.14 | $1,841,807.52 |
DisclosureSEC source: 0001376339-17-000076 · wf-form4_149384703159000.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 140,168 F1 · kind: Represents shares which became indirectly owned by the Reporting Person through a substitution of assets in a GRAT. These shares were contributed to the GRAT on May 10, 2016. Read SEC document |
| May 01, 2017 Filed Feb 8, 2019 16:34 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | OtherCommon Stock | 140,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-19-000008 · wf-form5_154966166131747.xml · nonDerivative · entry 3 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 140,168 F1 · kind: Transaction represents a mere change in form of beneficial ownership - transfer of shares from direct holdings to a family trust. Read SEC document |
| May 01, 2017 Filed Feb 8, 2019 16:34 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | OtherCommon Stock | 140,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-19-000008 · wf-form5_154966166131747.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320,460 F1 · kind: Transaction represents a mere change in form of beneficial ownership - transfer of shares from direct holdings to a family trust. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 16:52 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 50,486 | $8.50 | $429,136.05 |
DisclosureSEC source: 0001376339-17-000048 · wf-form4_148961110411689.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,312,306 Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 16:51 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantCommon Stock | 2,749 | $2.64 | $7,257.36 |
DisclosureSEC source: 0001534424-17-000012 · koob.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,173 F1 · price: These shares were issued pursuant to the issuer's Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under such plan. The shares were issued at a price of $2.64 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 30, 2016. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 16:35 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantCommon Stock | 1,014 | $6.65 | $6,743.10 |
DisclosureSEC source: 0001534424-16-001072 · koob.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,424 F1 · price: These shares were issued pursuant to the issuer's Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under such plan. The shares were issued at a price of $6.65 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2016. Read SEC document |
| June 06, 2016 Filed Jan 25, 2017 16:12 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GiftCommon Stock | 140,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-17-000010 · wf-form5_148537871534959.xml · nonDerivative · entry 1 KOOB CHARLES E · CIK 0001426480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362,792 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.